Jeil Pharmaceutical Co.,Ltd (271980.KS)

KRW 11640.0

(-5.6%)

Annual Balance Sheets

(In KRW)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 487.32 Billion 456.89 Billion 426.48 Billion 409.66 Billion 401.58 Billion 402.9 Billion
Total Current Assets 317.04 Billion 291.64 Billion 284.67 Billion 277.51 Billion 264.13 Billion 273.35 Billion
Cash And Short Term Investments 35.65 Billion 31.58 Billion 28 Billion 6.58 Billion 13.52 Billion 2.84 Billion
Cash and Cash Equivalents 32.99 Billion 31.44 Billion 25.96 Billion 3.89 Billion 13.51 Billion 2.49 Billion
Short Term Investments 2.66 Billion 142.45 Million 2.04 Billion 2.69 Billion 4.76 Million 350 Million
Net Receivables 166.22 Billion 156.36 Billion 148.99 Billion 157.32 Billion 162.32 Billion 182.06 Billion
Inventory 109.76 Billion 99.15 Billion 102.45 Billion 109.31 Billion 84.07 Billion 88.44 Billion
Other Current Assets 5.39 Billion 4.53 Billion 5.21 Billion 4.29 Billion 4.21 Billion 560.00
Total Non-Current Assets 170.28 Billion 165.25 Billion 141.81 Billion 132.15 Billion 137.45 Billion 129.54 Billion
Net PPE 137.04 Billion 138.4 Billion 125.7 Billion 115.54 Billion 121.61 Billion 120.48 Billion
Good Will And Intangible Assets 12.88 Billion 9.38 Billion 3.76 Billion 4.09 Billion 4.32 Billion 4.35 Billion
Good Will - - - - - -
Intangible Assets 12.88 Billion 9.38 Billion 3.76 Billion 4.09 Billion 4.32 Billion 4.35 Billion
Long-Term Investments 11.72 Billion 9.25 Billion 2.99 Billion -774.93 Million 923.93 Million 627.94 Million
Tax Assets 5.35 Billion 172.38 Million 1.45 Billion 3.32 Billion 2.35 Billion 944.39 Million
Other Non Current Assets 3.27 Billion 8.04 Billion 7.89 Billion 9.96 Billion 8.22 Billion 3.13 Billion
Other Assets - - 10.00 - - -
Total Liabilities 330.29 Billion 301.29 Billion 259.13 Billion 237.18 Billion 231.54 Billion 217.96 Billion
Total Current Liabilities 318.17 Billion 268.65 Billion 221.94 Billion 218.05 Billion 208.51 Billion 194.55 Billion
Account Payables 144.33 Billion 151.64 Billion 153.08 Billion 143.36 Billion 149.57 Billion 144.75 Billion
Tax Payables 448.24 Million 1.04 Billion 114.56 Million 3.43 Billion 4.24 Billion 1.35 Billion
Short Term Debt 80.51 Billion 44.9 Billion 32.2 Billion 38.14 Billion 14 Billion 17.97 Billion
Deferred Revenue 1.73 Billion 1.65 Billion 21.35 Billion 23.44 Billion 32.26 Billion 1.35 Billion
Other Current Liabilities 91.58 Billion 70.45 Billion 15.29 Billion 13.11 Billion 12.67 Billion 30.47 Billion
Total Non Current Liabilities 12.12 Billion 32.63 Billion 37.19 Billion 19.12 Billion 23.02 Billion 23.41 Billion
Long-Term Debt 4.45 Billion 5.44 Billion 8.14 Billion 11.16 Billion 18.41 Billion 19.9 Billion
Deferred Revenue Non Current 200.01 Million 227.11 Million 248.11 Million 379.41 Million 346.11 Million 257.11 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 7.67 Billion 26.96 Billion 630.00 710.00 -170.00 -310.00
Other Liabilities - 10.00 - - - -
Total Equity 157.03 Billion 155.59 Billion 167.34 Billion 172.47 Billion 170.04 Billion 184.93 Billion
Stock Holders Equity 158.57 Billion 157.9 Billion 168.21 Billion 172.39 Billion 170.04 Billion 184.93 Billion
Common Stock 7.35 Billion 7.35 Billion 7.35 Billion 7.35 Billion 7.35 Billion 7.35 Billion
Retained Earnings -20.19 Billion -20.32 Billion -10.41 Billion 2.84 Billion 5.21 Billion 18.85 Billion
Accumulated other comprehensive income 20.94 Billion 20.87 Billion 20.77 Billion 16.96 Billion 17.03 Billion 9.92 Billion
Common Stock Equity 158.57 Billion 157.9 Billion 168.21 Billion 172.39 Billion 170.04 Billion 184.93 Billion
Capital Lease Obligation 4.45 Billion 7.27 Billion 8.53 Billion 5.1 Billion 6.51 Billion -
Total Investments 14.39 Billion 9.39 Billion 5.03 Billion 1.91 Billion 928.69 Million 977.94 Million
Total Debt 84.96 Billion 50.35 Billion 40.35 Billion 49.3 Billion 32.42 Billion 37.87 Billion
Net Debt 51.97 Billion 18.9 Billion 14.39 Billion 45.41 Billion 18.9 Billion 35.38 Billion

Balance Sheet Charts